From bystander to key player: The mechanisms and therapeutic potential of IL-24 in liver diseases
- 16 October 2026
- journal article
- review article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1) , 1739
Abstract
Interleukin-24 (IL-24) was initially identified during investigations on melanoma differentiation, and it is a pivotal member of the IL-10 family. As a secreted cytokine, IL-24 is recognized as a tumor suppressor cytokine that induces apoptosis and inhibits angiogenesis. The liver is a unique immunotolerant organ that maintains metabolic homeostasis while continuously responding to insults, such as viral infections, toxic substances, and metabolic stress. In recent years, accumulating evidence has elucidated the role of IL-24 in the initiation and progression of hepatocellular carcinoma (HCC), demonstrating that this cytokine may suppress tumor progression by inducing tumor cell death and modulating antitumor immunity. However, compared with its relatively well-characterized functions in HCC, the role of IL-24 in non-neoplastic hepatopathies remains less defined. Current evidence, primarily derived from in vivo and in vitro experiments, suggests that IL-24 may exert hepatoprotective effects against acute and chronic liver injury by alleviating endoplasmic reticulum stress. Additionally, IL-24 modulates hepatic stellate cell activation and influences proinflammatory cytokine release during liver fibrosis, whereas it affects hepatocyte autophagy and metabolic reprogramming in metabolic dysfunction-associated steatotic liver disease, thereby potentially mitigating disease progression. This review comprehensively delineates the molecular characteristics of IL-24 and summarizes research progress on its roles in non-neoplastic liver diseases, particularly focusing on the underlying molecular mechanisms and possible therapeutic implications. This study additionally highlights the limitations of current evidence and outlines future research directions, aiming to provide a basis for future investigation of IL-24–targeted intervention strategies.Keywords
Funding Information
- Hebei Provincial Department of Education graduate Innovation Funding Program (CXZZBS2025110)
- National Natural Science Foundation of China (82470598)
This publication has 53 references indexed in Scilit:
- Intracellular IL-24 ameliorates lipid metabolic disorders in metabolic dysfunction-associated steatohepatitis by restoring the autophagy-lysosome pathwayCellular and Molecular Life Sciences, 2025
- Interleukin‐24: A Multidimensional Therapeutic for Treatment of Human DiseasesWIREs Nanomedicine and Nanobiotechnology, 2025
- Expression, Purification, and Polyethylene Glycol Site-Specific Modification of Recombinant Human Interleukin 24 in Escherichia coliThe Protein Journal, 2019
- IL-20 receptor cytokines in autoimmune diseasesJournal of Leukocyte Biology, 2018
- Role of MDA-7/IL-24 a Multifunction Protein in Human Diseases2018
- miR‐203a‐3p.1 targets IL‐24 to modulate hepatocellular carcinoma cell growth and metastasisFEBS Open Bio, 2017
- MDA-7/IL-24: Multifunctional Cancer Killing Cytokine2014
- Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in miceHepatology, 2012
- Replication-incompetent adenovirus vector-mediated MDA-7/IL-24 selectively induces growth suppression and apoptosis of hepatoma cell Line SMMC-7721Current Medical Science, 2008
- Melanoma Differentiation Associated Gene-7 (mda-7): A Novel Anti-Tumor Gene for Cancer Gene TherapyMolecular Medicine, 2001